China Biologics and Biosimilars Market Research Report Forecast 2017-2021

March 2017 | 131 pages | ID: C818794EC49EN
S&P Consulting

Abstracts

The China Biologics and Biosimilars Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Biologics and Biosimilars industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Biologics and Biosimilars market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

The Major players reported in the market include:
Pfizer
Roche
Amgen
AbbVie
Sanofi
Johnson & Johnson
Novo Nordisk
Novartis
company 9
China Biologics and Biosimilars Market: Product Segment Analysis
Biologics
Biosimilars

• Type III

China Biologics and Biosimilars Market: Application Segment Analysis
Tumor
Diabetes
Cardiovascular

REASONS FOR BUYING THIS REPORT

This report provides pin-point analysis for changing competitive dynamics

• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

CHAPTER 1 BIOLOGICS AND BIOSIMILARS MARKET OVERVIEW

1.1 Product Overview and Scope of Biologics and Biosimilars
1.2 Biologics and Biosimilars Market Segmentation by Type
  1.2.1 China Production Market Share of Biologics and Biosimilars by Biologicsn 2016
  1.2.1 Biologics
  1.2.2 Biosimilars
  1.2.3 Type III
1.3 Biologics and Biosimilars Market Segmentation by Application
  1.3.1 Biologics and Biosimilars Consumption Market Share by Application in 2016
  1.3.2 Tumor
  1.3.3 Diabetes
  1.3.4 Cardiovascular
1.4 China Market Size Sales (Value) and Revenue (Volume) of Biologics and Biosimilars (2012-2021)

CHAPTER 2 CHINA ECONOMIC IMPACT ON BIOLOGICS AND BIOSIMILARS INDUSTRY

2.1 China Macroeconomic Environment Analysis
  2.1.1 China Macroeconomic Analysis
  2.1.2 China Macroeconomic Environment Development Trend
2.2 Effects to Biologics and Biosimilars Industry

CHAPTER 3 CHINA BIOLOGICS AND BIOSIMILARS MARKET COMPETITION BY MANUFACTURERS

3.1 China Biologics and Biosimilars Production and Share by Manufacturers (2015 and 2016)
3.2 China Biologics and Biosimilars Revenue and Share by Manufacturers (2015 and 2016)
3.3 China Biologics and Biosimilars Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Biologics and Biosimilars Manufacturing Base Distribution, Production Area and Product Type
3.5 Biologics and Biosimilars Market Competitive Situation and Trends
  3.5.1 Biologics and Biosimilars Market Concentration Rate
  3.5.2 Biologics and Biosimilars Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 CHINA BIOLOGICS AND BIOSIMILARS CAPACITY, PRODUCTION, REVENUE, CONSUMPTION, EXPORT AND IMPORT (2012-2017)

4.1 China Biologics and Biosimilars Capacity, Production and Growth (2012-2017)
4.2 China Biologics and Biosimilars Revenue and Growth (2012-2017)
4.3 China Biologics and Biosimilars Production, Consumption, Export and Import (2012-2017)

CHAPTER 5 CHINA BIOLOGICS AND BIOSIMILARS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 China Biologics and Biosimilars Production and Market Share by Type (2012-2017)
5.2 China Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
5.3 China Biologics and Biosimilars Price by Type (2012-2017)
5.4 China Biologics and Biosimilars Production Growth by Type (2012-2017)

CHAPTER 6 CHINA BIOLOGICS AND BIOSIMILARS MARKET ANALYSIS BY APPLICATION

6.1 China Biologics and Biosimilars Consumption and Market Share by Application (2012-2017)
6.2 China Biologics and Biosimilars Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

CHAPTER 7 CHINA BIOLOGICS AND BIOSIMILARS MANUFACTURERS ANALYSIS

7.1 Pfizer
  7.1.1 Company Basic Information, Manufacturing Base and Competitors
  7.1.2 Product Type, Application and Specification
  7.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.1.4 Business Overview
7.2 Roche
  7.2.1 Company Basic Information, Manufacturing Base and Competitors
  7.2.2 Product Type, Application and Specification
  7.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.2.4 Business Overview
7.3 Amgen
  7.3.1 Company Basic Information, Manufacturing Base and Competitors
  7.3.2 Product Type, Application and Specification
  7.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.3.4 Business Overview
7.4 AbbVie
  7.4.1 Company Basic Information, Manufacturing Base and Competitors
  7.4.2 Product Type, Application and Specification
  7.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.4.4 Business Overview
7.5 Sanofi
  7.5.1 Company Basic Information, Manufacturing Base and Competitors
  7.5.2 Product Type, Application and Specification
  7.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.5.4 Business Overview
7.6 Johnson & Johnson
  7.6.1 Company Basic Information, Manufacturing Base and Competitors
  7.6.2 Product Type, Application and Specification
  7.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.6.4 Business Overview
7.7 Novo Nordisk
  7.7.1 Company Basic Information, Manufacturing Base and Competitors
  7.7.2 Product Type, Application and Specification
  7.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.7.4 Business Overview
7.8 Novartis
  7.8.1 Company Basic Information, Manufacturing Base and Competitors
  7.8.2 Product Type, Application and Specification
  7.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.8.4 Business Overview
7.9 company
  7.9.1 Company Basic Information, Manufacturing Base and Competitors
  7.9.2 Product Type, Application and Specification
  7.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.9.4 Business Overview
…

CHAPTER 8 BIOLOGICS AND BIOSIMILARS MANUFACTURING COST ANALYSIS

8.1 Biologics and Biosimilars Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Biologics and Biosimilars

CHAPTER 9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Biologics and Biosimilars Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Biologics and Biosimilars Major Manufacturers in 2015
9.4 Downstream Buyers

CHAPTER 10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

CHAPTER 11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

CHAPTER 12 CHINA BIOLOGICS AND BIOSIMILARS MARKET FORECAST (2017-2021)

12.1 China Biologics and Biosimilars Production, Revenue Forecast (2017-2021)
12.2 China Biologics and Biosimilars Production, Consumption Forecast by Regions (2017-2021)
12.3 China Biologics and Biosimilars Production Forecast by Type (2017-2021)
12.4 China Biologics and Biosimilars Consumption Forecast by Application (2017-2021)
12.5 Biologics and Biosimilars Price Forecast (2017-2021)

CHAPTER 13 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Biologics and Biosimilars
Figure China Production Market Share of Biologics and Biosimilars by Biologicsn 2016
Table Biologics and Biosimilars Consumption Market Share by Application in 2016
Figure China Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2021)
Table China Biologics and Biosimilars Capacity of Key Manufacturers (2015 and 2016)
Table China Biologics and Biosimilars Capacity Market Share of Key Manufacturers (2015 and 2016)
Figure China Biologics and Biosimilars Capacity of Key Manufacturers in 2015
Figure China Biologics and Biosimilars Capacity of Key Manufacturers in 2016
Table China Biologics and Biosimilars Production of Key Manufacturers (2015 and 2016)
Table China Biologics and Biosimilars Production Share by Manufacturers (2015 and 2016)
Figure 2015 Biologics and Biosimilars Production Share by Manufacturers
Figure 2016 Biologics and Biosimilars Production Share by Manufacturers
Table China Biologics and Biosimilars Revenue (Million USD) by Manufacturers (2015 and 2016)
Table China Biologics and Biosimilars Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Biologics and Biosimilars Revenue Share by Manufacturers
Table 2016 China Biologics and Biosimilars Revenue Share by Manufacturers
Table China Market Biologics and Biosimilars Average Price of Key Manufacturers (2015 and 2016)
Figure China Market Biologics and Biosimilars Average Price of Key Manufacturers in 2015
Table Manufacturers Biologics and Biosimilars Manufacturing Base Distribution and Sales Area
Table Manufacturers Biologics and Biosimilars Product Type
Figure Biologics and Biosimilars Market Share of Top 3 Manufacturers
Figure Biologics and Biosimilars Market Share of Top 5 Manufacturers
Table Church & Dwight Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Church & Dwight Biologics and Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Church & Dwight Biologics and Biosimilars Market Share (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Pfizer Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer Biologics and Biosimilars Market Share (2012-2017)
Table Roche Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Roche Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
Table Roche Biologics and Biosimilars Market Share (2012-2017)
Table Amgen Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Amgen Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
Table Amgen Biologics and Biosimilars Market Share (2012-2017)
Table AbbVie Basic Information, Manufacturing Base, Production Area and Its Competitors
Table AbbVie Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
Table AbbVie Biologics and Biosimilars Market Share (2012-2017)
Table Sanofi Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Sanofi Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
Table Sanofi Biologics and Biosimilars Market Share (2012-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Johnson & Johnson Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
Table Johnson & Johnson Biologics and Biosimilars Market Share (2012-2017)
Table Novo Nordisk Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Novo Nordisk Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
Table Novo Nordisk Biologics and Biosimilars Market Share (2012-2017)
Table Novartis Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Novartis Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
Table Novartis Biologics and Biosimilars Market Share (2012-2017)
Table company 9 Basic Information, Manufacturing Base, Production Area and Its Competitors
Table company 9 Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
Table company 9 Biologics and Biosimilars Market Share (2012-2017)
Figure Production Revenue Share of Biologics and Biosimilars by Type (2012-2017)
Figure 2015 Revenue Market Share of Biologics and Biosimilars by Type
Table China Biologics and Biosimilars Price by Type (2012-2017)
Figure China Biologics and Biosimilars Production Growth by Type (2012-2017)
Table China Biologics and Biosimilars Consumption by Application (2012-2017)
Table China Biologics and Biosimilars Consumption Market Share by Application (2012-2017)
Figure China Biologics and Biosimilars Consumption Market Share by Application in 2015
Table China Biologics and Biosimilars Consumption Growth Rate by Application (2012-2017)
Figure China Biologics and Biosimilars Consumption Growth Rate by Application (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biologics and Biosimilars
Figure Manufacturing Process Analysis of Biologics and Biosimilars
Figure Biologics and Biosimilars Industrial Chain Analysis
Table Raw Materials Sources of Biologics and Biosimilars Major Manufacturers in 2015
Table Major Buyers of Biologics and Biosimilars
Table Distributors/Traders List
Figure China Biologics and Biosimilars Capacity, Production and Growth Rate Forecast (2017-2021)
Figure China Biologics and Biosimilars Revenue and Growth Rate Forecast (2017-2021)
Table China Biologics and Biosimilars Production, Import, Export and Consumption Forecast (2017-2021)
Table China Biologics and Biosimilars Production Forecast by Type (2017-2021)
Table China Biologics and Biosimilars Consumption Forecast by Application (2017-2021)